Was bewirkt leitlinienkonforme Therapie in der Behandlung der allergischen Rhinokonjunktivitis?

Schlüsselwörter

allergische Rhinokonjunktivitis - Leitlinienkonforme Therapie - Therapiecompliance

Key words

allergic rhinoconjunctivitis - guideline-confirming treating - therapy compliance

Literatur

• 1 ARIA At-A-Glance Pocket Reference. www.whiar.org; Zugriff: 8.12.2007
• 2 AWMF .Die nasale Hyperreaktivität. Die allergische Rhinitis und ihre Differenzialdiagnosen. Konsensusbericht zur Pathophysiologie, Klassifikation, Diagnose und Therapie. online Nr. 017/058; . 1996
• 3 Asher M I, Montefort S, Bjorksten B, Lai C K, Strachan D P, Weiland S K, Williams H. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys.  Lancet. 2006;  368 733-743
• 4 Bachert C, Borchard U, Wedi B, Klimek L, Rasp G, Riechelmann H, Schultze-Werninghaus G, Wahn U, Ring J. Leitlinie der DGAI zur allergischen Rhinokonjunktivitis.  Allergologie. 2003;  26 147-162
• 5 Bachert C, Lange B, Virchow J C. Asthma und allergische Rhinitis. Eine Erkrankung mit zwei Gesichtern. Stuttgart; Thieme 2005
• 6 Bauchau V, Durham S R. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis.  Allergy. 2005;  60 350-353
• 7 Bauchau V, Durham S R. Prevalence and rate of diagnosis of allergic rhinitis in Europe.  Eur Respir J. 2004;  24 758-764
• 8 Bousquet J. Allergic rhinitis and its impact on asthma. Vienna; In: XXV EAACI Congress 2006
• 9 Bousquet J, Annesi-Maesano I, Carat F, Leger D, Rugina M, Pribil C, El H asnaoui A, Chanal I. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group.  Clin Exp Allergy. 2005;  35 728-732
• 10 Bousquet J, Lund V J, van Cauwenberge P, Bremard-Oury C, Mounedji N, Stevens M T, El-Akkad T. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial.  Allergy. 2003;  58 733-741
• 11 Bousquet J, Neukirch F, Bousquet P J, Gehano P, Klossek J M, Le G al M, Allaf B. Severity and impairment of allergic rhinitis in patients consulting in primary care.  J Allergy Clin Immunol. 2006;  117 158-162
• 12 Bousquet J, van Cauwenberge P, Ait K haled N. et al . (2006) Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GALEN).  Allergy. 2006;  61 1086-1096
• 13 Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and the impact of asthma (ARIA). Executive Summary.  Allergy. 2002;  57 841-855
• 14 Bousquet J, Van Cauwenberge P B, Khaltaev N. Allergic rhinitis and its impact on asthma.  J Allergy Clin Immunol. 2001;  108 (5 Suppl) s147-s334
• 15 Demoly P, Allaert F A, Lecasble M, Bousquet J. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma).  Allergy. 2003;  58 672-675
• 16 Feinstein A R, Horwitz R I. Problems in the „evidence” of „evidence-based medicine”.  Am J Med. 1997;  103 529-535
• 17 Grimshaw J M, Russell I T. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.  Lancet. 1993;  342 1317-1322
• 18 Heinrich J, Richter K, Frye C, Meyer I, Wolke G, Wjst M, Nowak D, Magnussen H, Wichmann H E. [European Community Respiratory Health Survey in Adults (ECRHS)].  Pneumologie. 2002;  56 297-303
• 19 Janson C, Anto J, Burney P, Chinn S, de Marco R, Heinrich J, Jarvis D, Kuenzli N, Leynaert B, Luczynska C, Neukirch F, Svanes C, Sunyer J, Wjst M. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II.  Eur Respir J. 2001;  18 598-611
• 20 Johansson S G, Bieber T, Dahl R, Friedmann P S, Lanier B Q, Lockey R F, Motala C, Ortega M artell JA, Platts-Mills T A, Ring J, Thien F, Van Cauwenberge P, Williams H C. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.  J Allergy Clin Immunol. 2004;  113 832-836
• 21 Marple B F, Fornadley J A, Patel A A, Fineman S M, Fromer L, Krouse J H, Lanier B Q, Penna P. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction.  Otolaryngol Head Neck Surg. 2007;  136 S107-124
• 22 Maurer M, Zuberbier T. Undertreatment of rhinitis symptoms in Europe: findings from a cross-sectional questionnaire survey.  Allergy. 2007;  62 1057-1063
• 23 Mösges R, Klimek L. Today’s allergic rhinitis patients are different: new factors that may play a role.  Allergy. 2007;  62 969-975
• 24 Mösges R, Koberlein J. [New generation antihistamines as monotherapy or in combination. What is the relevance for daily clinical routine for allergic rhinoconjunctivitis].  HNO. 2007;  55 457-464
• 25 Ollenschläger G, Kirchner H, Fiene M. Leitlinien in der Medizin – scheitern sie an der praktischen Umsetzung?.  Internist. 2001;  42 473-483
• 26 Ring J, Fuchs T, Schultze-Werninghaus G. Weißbuch Allergie. München; Urban & Vogel 2004
• 27 Schramm B, Ehlken B, Smala A, Quednau K, Berger K, Nowak D. Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study.  Eur Respir J. 2003;  21 116-122
• 28 Wang D Y, Niti M, Smith J D, Yeoh K H, Ng T P. Rhinitis: do diagnostic criteria affect the prevalence and treatment?.  Allergy. 2002;  57 150-154
• 29 Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee.  Lancet. 1998;  351 1225-1232
• 30 Bachert C. Leitlinie zur allergischen Rhinokonjunktivitis.  Allergologie. 2003;  26 133-134